Here’s whether NeoGenomics, Inc. (NEO) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+9.76% over 10 days); RSI 36 — healthy momentum range; strong 1-year return of +116.4%; 3-month momentum positive (+67.5%). Currently 10.8% off its 52-week high. Score: +7/7.
NEO is in a confirmed uptrend, trading above both its 50-day ($11.98) and 200-day ($10.70) moving averages. An RSI of 36.2 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +116.4% compares to +16.5% for SPY (beat the market by 99.9%).
$10,000 invested 1 year ago→ $21,636 today
vs. S&P 500 (SPY) — same period beat market by 99.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($10.70)
✓Above 50-day MA ($11.98)
✓RSI(14) neutral zone (30–70) — currently 36.2
✓Positive return (+116.4%)
!Within 10% of period high (−10.8%)
Period Range $13.89
$4.72$15.57
RSI (14) 36.2
0 · OversoldOverbought · 100
Key Metrics
Price$13.89
Period Return+116.4%
Period High$15.57
Period Low$4.72
Drawdown−10.8%
MA-50$11.98
MA-200$10.70
RSI (14)36.2
Avg Volume (30d)3.6M
vs. SPYbeat by 99.9%
Return Rank#81 of 999
Trend Signals
Price is above the 200-day moving average ($10.70)